Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

NCT02960399 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT02960399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02960399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
Lead sponsor
University of South Florida
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2015
Completion date
December 31, 2017
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common variable immune deficiency, specific antibody deficiency, x-linked agammaglobulinemia